Compounds > bromodeoxyuridine
Page last updated: 2024-08-17

bromodeoxyuridine and Canine Diseases

bromodeoxyuridine has been researched along with Canine Diseases in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (40.00)18.2507
2000's6 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iidaka, T; Masegi, T; Noda, A; Sakai, H; Shirai, N; Yanai, T1
Dierendonck, JH; Nederbragt, H; Rutteman, GR; Teske, E; van Garderen, E; Zacchetti, A1
Baba, E; Nabetani, T; Sasai, K; Tani, H1
Dziegiel, P; Kanzawa, H; Madej, JA; Nowak, M1
Griffey, S; Metzger, L; Théon, AP1
Crompton, NE; Fodor, G; Hauser, B; Kaser-Hotz, B; Ruckstuhl, H; Schwyn, U1
Blattmann, H; Crompton, NE; Hauser, B; Kaser-Hotz, B; Klink, B; Parvis, A; Ruslander, D; Schwyn, U1
Ishikawa, K; Iwasaki, T; Kati, S; Lackner, AA; Masegi, T; Ohta, J; Sakai, H; Yanai, T; Yoshida, K1
Hong, SH; Kadosawa, T; Matsunaga, S; Mochizuki, M; Nishimura, R; Nozaki, K; Sasaki, N1
de Mora, F; Ferrer, L; Fondati, A; Fondevila, D; Ordeix, L1

Other Studies

10 other study(ies) available for bromodeoxyuridine and Canine Diseases

ArticleYear
Proliferative activity of canine mast cell tumours evaluated by bromodeoxyuridine incorporation and Ki-67 expression.
    Journal of comparative pathology, 2002, Volume: 127, Issue:4

    Topics: Animals; Bromodeoxyuridine; Cell Count; Cell Division; Cell Nucleus; Dog Diseases; Dogs; Immunoenzyme Techniques; Ki-67 Antigen; Mastocytoma; Mitotic Index; Neoplasm Staging; Skin Neoplasms

2002
Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2003, Volume: 111, Issue:3

    Topics: Animals; Bromodeoxyuridine; Cell Division; Dog Diseases; Dogs; Female; Immunohistochemistry; Ki-67 Antigen; Lymphoma; Mammary Neoplasms, Animal; Proliferating Cell Nuclear Antigen

2003
Proliferative responses to canine thyroglobulin of peripheral blood mononuclear cells from hypothyroid dogs.
    The Journal of veterinary medical science, 2005, Volume: 67, Issue:4

    Topics: Animals; Autoantibodies; Bromodeoxyuridine; CD4 Antigens; CD8 Antigens; Cell Proliferation; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Hypothyroidism; Immunoglobulin G; Leukocytes, Mononuclear; T-Lymphocyte Subsets; Thy-1 Antigens; Thyroglobulin

2005
Immunohistochemical identification method of tumour cells in the S phase of mitotic cycle and its usefulness in diagnostics of mammary gland adenocarcinomas in bitches.
    Polish journal of veterinary sciences, 2006, Volume: 9, Issue:1

    Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Division; Dog Diseases; Dogs; Female; Immunohistochemistry; Ki-67 Antigen; Mammary Neoplasms, Animal; Mitosis; Proliferating Cell Nuclear Antigen; S Phase

2006
In situ analysis of cellular proliferation in canine, feline and equine tumors by immunohistochemistry: a comparison of bromodeoxyuridine, proliferating cell nuclear antigen, and interchromatin-associated antigen immunostaining techniques.
    Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc, 1994, Volume: 6, Issue:4

    Topics: Animals; Antibodies, Monoclonal; Biomarkers, Tumor; Bromodeoxyuridine; Cat Diseases; Cats; Cell Division; Dog Diseases; Dogs; Horse Diseases; Horses; Immunohistochemistry; Neoplasms; Proliferating Cell Nuclear Antigen; Statistics as Topic

1994
[Determination of the potential doubling time of tumors using bromodeoxyuridine and flow cytometry].
    Schweizer Archiv fur Tierheilkunde, 1997, Volume: 139, Issue:10

    Topics: Animals; Antimetabolites, Antineoplastic; Biopsy; Bromodeoxyuridine; Cat Diseases; Cats; Dog Diseases; Dogs; Flow Cytometry; Neoplasms; Prognosis; Time Factors

1997
Potential tumour doubling time: determination of Tpot for various canine and feline tumours.
    Veterinary research communications, 1998, Volume: 22, Issue:4

    Topics: Animals; Biopsy; Bromodeoxyuridine; Cat Diseases; Cats; Cell Cycle; DNA, Neoplasm; Dog Diseases; Dogs; Female; Flow Cytometry; Kinetics; Male; Mitotic Index; Neoplasms; Prognosis; Regression Analysis; Time Factors

1998
Proliferative potential of canine oral epulides and malignant neoplasms assessed by bromodeoxyuridine labeling.
    Veterinary pathology, 1999, Volume: 36, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Bromodeoxyuridine; Carcinoma, Squamous Cell; Dog Diseases; Dogs; Female; Fibrosarcoma; Gingival Diseases; Gingival Neoplasms; Male; Melanoma; Mitotic Index; Mouth Neoplasms

1999
In vitro retinoid-induced growth inhibition and morphologic differentiation of canine osteosarcoma cells.
    American journal of veterinary research, 2000, Volume: 61, Issue:1

    Topics: Alitretinoin; Animals; Antimetabolites; Antineoplastic Agents; Bone Neoplasms; Bromodeoxyuridine; Cell Division; DNA; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Microscopy, Phase-Contrast; Osteosarcoma; Tretinoin; Tumor Cells, Cultured

2000
Assessment of proliferative activity of canine dermal mast cells by bromodeoxyuridine and proliferating cell nuclear antigen labelling.
    Veterinary dermatology, 2001, Volume: 12, Issue:6

    Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Dermatitis, Atopic; Dog Diseases; Dogs; Female; Immunohistochemistry; Male; Mast Cells; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Skin Physiological Phenomena

2001